Philipp Wolber1, David Schwarz2, Maximilian Niemczyk2, Uta Drebber3, Jens Peter Klußmann2, Moritz Meyer2. 1. Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. philipp.Wolber@uk-koeln.de. 2. Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. 3. Department of Pathology, Medical Faculty, University of Cologne, Cologne, Germany.
Abstract
PURPOSE: Podoplanin is a membrane-bound glycoprotein that plays a role in lymphangiogenesis. Several studies suggest a role of podoplanin in head-and-neck cancer. The purpose of the current study was to evaluate the role of podoplanin as a prognostic marker in nasopharyngeal carcinoma. METHODS: In a monocentric retrospective analysis, data of 42 patients with primary diagnosis of nasopharyngeal carcinoma (diagnosed between 2004 and 2017) were examined regarding the relationship between the immunohistochemically analyzed podoplanin expression status and corresponding clinical and oncological parameters. RESULTS: The mean age was 56.6 years. The majority (61.9%) had an advanced tumor stage (T3-T4). The 5-year overall survival was 54%. 33% showed a positive expression of podoplanin. In patients with tumors with podoplanin expression, 5-year overall survival was 15%, while in patients with tumors without podoplanin expression, 5-year overall survival was 75% (p = 0.017, univariate analysis). In multivariate analysis, podoplanin expression was shown to be the only independent prognostic marker for nasopharyngeal carcinoma (p = 0.025). CONCLUSION: This retrospective study shows that podoplanin expression is a potential prognostic marker for nasopharyngeal carcinomas. In the future, clinical use could filter out more aggressive courses and allow therapy escalation in those cases.
PURPOSE:Podoplanin is a membrane-bound glycoprotein that plays a role in lymphangiogenesis. Several studies suggest a role of podoplanin in head-and-neck cancer. The purpose of the current study was to evaluate the role of podoplanin as a prognostic marker in nasopharyngeal carcinoma. METHODS: In a monocentric retrospective analysis, data of 42 patients with primary diagnosis of nasopharyngeal carcinoma (diagnosed between 2004 and 2017) were examined regarding the relationship between the immunohistochemically analyzed podoplanin expression status and corresponding clinical and oncological parameters. RESULTS: The mean age was 56.6 years. The majority (61.9%) had an advanced tumor stage (T3-T4). The 5-year overall survival was 54%. 33% showed a positive expression of podoplanin. In patients with tumors with podoplanin expression, 5-year overall survival was 15%, while in patients with tumors without podoplanin expression, 5-year overall survival was 75% (p = 0.017, univariate analysis). In multivariate analysis, podoplanin expression was shown to be the only independent prognostic marker for nasopharyngeal carcinoma (p = 0.025). CONCLUSION: This retrospective study shows that podoplanin expression is a potential prognostic marker for nasopharyngeal carcinomas. In the future, clinical use could filter out more aggressive courses and allow therapy escalation in those cases.
Authors: Leah N Cueni; Ivan Hegyi; Jay W Shin; Andrea Albinger-Hegyi; Silke Gruber; Rainer Kunstfeld; Holger Moch; Michael Detmar Journal: Am J Pathol Date: 2010-07-08 Impact factor: 4.307
Authors: K C Allen Chan; John K S Woo; Ann King; Benny C Y Zee; W K Jacky Lam; Stephen L Chan; Sam W I Chu; Constance Mak; Irene O L Tse; Samantha Y M Leung; Gloria Chan; Edwin P Hui; Brigette B Y Ma; Rossa W K Chiu; Sing-Fai Leung; Andrew C van Hasselt; Anthony T C Chan; Y M Dennis Lo Journal: N Engl J Med Date: 2017-08-10 Impact factor: 91.245
Authors: Simon F Preuss; Andreas Anagiotos; Inga M C Seuthe; Uta Drebber; Inga Wedemeyer; Matthias Kreppel; Robert Semrau; Guy D Eslick; Jens Peter Klussmann; Christian U Huebbers Journal: Eur Arch Otorhinolaryngol Date: 2014-06-01 Impact factor: 2.503